Abstract
Three differently sized, highly dispersed platinum nanoparticle (Pt-NP) preparations were generated by supercritical fluid reactive deposition (SFRD) and deposited on a β-cyclodextrin matrix. The average particle size and size distribution were steered by the precursor reduction conditions, resulting in particle preparations of <20, <100 and >100 nm as characterised by TEM and SEM. As reported previously, these Pt-NPs were found to cause DNA strand breaks in human colon carcinoma cells (HT29) in a concentration- and time-dependent manner and a distinct size dependency. Here, we addressed the question whether Pt-NPs might affect directly DNA integrity in these cells and thus behave analogous to platinum-based chemotherapeutics such as cisplatin. Therefore, DNA-associated Pt as well as the translocation of Pt-NPs through a Caco-2 monolayer was quantified by ICP-MS. STEM imaging demonstrated that Pt-NPs were taken up into HT29 cells in their particulate and aggregated form, but appear not to translocate into the nucleus or interact with mitochondria. The platinum content of the DNA of HT29 cells was found to increase in a time- and concentration-dependent manner with a maximal effect at 1,000 ng/cm2. ICP-MS analysis of the cell culture medium indicated the formation of soluble Pt species, although to a limited extent. The observations suggest that DNA strand breaks mediated by metallic Pt-NPs are caused by Pt ions forming during the incubation of cells with these nanoparticles.
Similar content being viewed by others
Abbreviations
- BF:
-
Bright field
- Caco-2:
-
Human colon carcinoma cell line
- Cisplatin:
-
Cis-diaminedichloridoplatinum
- DMEM:
-
Dulbecco’s modified Eagle medium
- FCS:
-
Foetal calf serum
- GIT:
-
Gastrointestinal tract
- HBSS:
-
Hanks’ balanced salt solution
- HT29:
-
Human colon carcinoma cell line
- ICP-MS:
-
Inductively coupled plasma mass spectrometry
- INT:
-
2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium
- LDH:
-
Lactate dehydrogenase
- LOD:
-
Limit of detection
- LOQ:
-
Limit of quantification
- PSD:
-
Particle size distribution
- Pt:
-
Platinum
- PBS:
-
Phosphate-buffered saline
- Pt(COD)Me2 :
-
1,5-(cyclooctadiene)dimethylplatinum(II)
- Pt-NP:
-
Platinum nanoparticle
- P/S:
-
Penicillin/streptomycin
- ROS:
-
Reactive oxygen species
- sc-CO2 :
-
Supercritical carbon dioxide
- SFRD:
-
Supercritical fluid reactive deposition
- SOD:
-
Superoxide dismutase
- SOP:
-
Standard operating procedure
- SRB:
-
Sulforhodamine B
- STEM:
-
Scanning transmission electron microscopy
- TEM:
-
Transmission electron microscopy
- WST:
-
Water-soluble tetrazolium salt
References
Alt F, Eschnauer HR, Mergler B, Messerschmidt J, Tölg G (1997) A contribution to the ecology and enology of platinum. Fresenius J Anal Chem 357:1013–1019. doi:10.1007/s002160050296
Artelt S, Creutzenberg O, Kock H, Levsen K, Nachtigall D, Heinrich U, Rühle T, Schlögl R (1999) Bioavailability of fine dispersed platinum as emitted from automotive catalytic converters: a model study. Sci Total Environ 228:219–242. doi:10.1016/S0048-9697(99)00049-2
Asharani PV, Xinyi Ng, Prakash Hande M, Valiyaveettil S (2010) DNA damage and p53-mediated growth arrest in human cells treated with platinum nanoparticles. Nanomedicine 5(1):51–64. doi:10.2217/nnm.09.85
Borm PJA, Robbins D, Haubold S, Kuhlbush T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Kademann J, Krutmann J, Warheit D, Oberdörster E (2006) The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 3:11. doi:10.1186/1743-8977-3-11
Ciccarelli RB, Solomon MJ, Varshavsky A, Lippard SJ (1985) In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking and inhibition of replication. Biochemistry 24:7533–7540. doi:10.1021/bi00347a005
Columbo C, Monhemius JA, Plant JA (2008a) The estimation of the bioavailabilities of platinum, palladium and rhodium in vehicle exhaust catalysts and road dusts using a physiologically based extraction test. Sci Total Environ 389:46–51. doi:10.1016/j.scitotenv.2007.08.002
Columbo C, Monhemius JA, Plant JA (2008b) Platinum, palladium and rhodium release from vehicle exhaust catalysts and road dust exposed to simulated lung fluids. Ecotox Environ Safe 71:722–730. doi:10.1016/j.ecoenv.2007.11.011
Donaldson K, Tran L, Jimenez LA, Duffin R, Newby DE, Mills N, MacNee W, Stone V (2005) Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol 2:10. doi:10.1186/1743-8977-2-10
Elder A, Yang H, Gwiazda R, Teng X, Thurston S, He H, Oberdörster G (2007) Testing nanomaterials of unknown toxicity: an example based on platinum nanoparticles of different shapes. Adv Mater 19:3124–3129. doi:10.100./adma.200701962
Grès M, Julian B, Bourriè M, Meunier V, Roques C, Berger M, Baulence X, Berger Y, Fabre G (1998) Correlation between oral drug absorption in humans and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharmaceut Res 15:726–733
Hoppstock K (2001) Platingruppenelemente in der Umwelt. Nachr Chem Tech 49(11):1305–1309. doi:10.1002/nadc.20010491111
Hoppstock K, Alt F (1999) Voltametrische Bestimmung von Platin und Rhodium in Umweltkompartimenten und biologischen Materialien. In: Zereini F, Alt F (eds) Emissionen von Platinmetallen. Springer, Berlin, Heidelberg, pp 230–257
Jordan P, Carmo-Fonseca M (2000) Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol Life Sci 57:1229–1235. doi:10.1007/PL00000762
Kajita M, Hikosaka K, Litsuka M, Kanayama A, Toshima N, Miyamoto Y (2007) Platinum nanoparticle is a useful scavenger of superoxide anion and hydrogen peroxide. Free Radic Res 41(6):615–626. doi:10.1080/10715760601169679
López T, Figueras F, Manjarrez J, Bustos J, Alvarez M, Silvestre-Albero J, Rodríguez-Reinoso F, Martínez-Ferre A, Martínez E (2010) Catalytic nanomedicine: a new field in antitumor treatment using supported platinum nanoparticles. In vitro DNA degradation and in vivo test with C6 animal model on Wistar rats. Eur J Med Chem 45(5):1982–1990. doi:10.1016/j.ejmech.2010.01.043
Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839. doi:10.1289/ehp.7339
Pelka J, Gehrke H, Esselen M, Türk M, Crone M, Bräse S, Muller T, Blank H, Send W, Zibat V, Brenner P, Schneider R, Gerthsen D, Marko D (2009) Cellular uptake of platinum nanoparticles in human colon carcinoma cells and their impact on cellular redox systems and DNA integrity. Chem Res Tox 22:649–659. doi:10.1021/tx800354g
Porcel E, Liehn S, Remita H, Usami N, Kobayashi K, Furusawa Y, Le Sech C, Lacombe S (2010) Platinum nanoparticles: a promising material for future cancer therapy? Nanotechnology 21(8):085103. doi:10.1088/0957-4484/21/8/085103
Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric assay for anticancer-drug screening. J Natl Cancer Inst 82:1107–1112. doi:10.1093/jnci/82.13.1107
Watanabe A, Kajita M, Kim J, Kanayama A, Takahashi K, Mashino T, Miyamoto Y (2009) In vitro free radical scavenging activity of platinum nanoparticles. Nanotechnology 20:455105
Zample DB, Lippard SJ (1995) Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem Sci 20:435–439. doi:10.1016/S0968-0004(00)89095-7
Zereini F, Alt F, Messerschmidt J, von Bohlen A, Liebl K, Puttmann W (2004) Concentration and distribution of platinum group elements (Pt, Pd, Rh) in airborne particulate matter in Frankfurt am Main, Germany. Environ Sci Technol 38:1686–1692
Zereini F, Wiseman C, Puttmann W (2007) Changes in palladium, platinum, and rhodium concentrations, and their spatial distribution in soils along a major highway in Germany from 1994 to 2004. Environ Sci Technol 41:451–456
Zhong CJ, Maye MM, Luo J, Kariuki N (2004) Nanoparticles in catalysis. In: Rotello V (ed) Nanoparticles: building blocks for nanotechnology. Kluwer Academics, Plenum Publishers, New York, pp 113–140
Acknowledgments
This work has been partly performed within the project E1.1 of the DFG Research Center for Functional Nanostructures (CFN). It has been further supported by a grant from the Ministry of Science, Research and the Arts of Baden-Württemberg (Az: 7713.14-300).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gehrke, H., Pelka, J., Hartinger, C.G. et al. Platinum nanoparticles and their cellular uptake and DNA platination at non-cytotoxic concentrations. Arch Toxicol 85, 799–812 (2011). https://doi.org/10.1007/s00204-010-0636-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-010-0636-3